Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

F T Koster

Showing results (41-50 of 49) with videos related to

Pageof 5
Sort By:
You have reached the last page of results.This site can display upto 49 results.
Virology|December 24, 1997
Hantavirus pulmonary syndrome: CD8+ and CD4+ cytotoxic T lymphocytes to epitopes on Sin Nombre virus nucleocapsid protein isolated during acute illnessF A Ennis, J Cruz, C F Spiropoulou, et al.
Clinical Infectious Diseases : an Official Publication of the Infectious Diseases Society of America|December 10, 1999
Hantavirus pulmonary syndrome in pregnancyM J Howard, T J Doyle, F T Koster, et al.
Clinical Infectious Diseases : an Official Publication of the Infectious Diseases Society of America|March 1, 1992
Vasculitic and encephalitic complications associated with Coccidioides immitis infection of the central nervous system in humans: report of 10 cases and reviewP L Williams, R Johnson, D Pappagianis, et al.
The Journal of Infectious Diseases|January 7, 1999
High levels of cytokine-producing cells in the lung tissues of patients with fatal hantavirus pulmonary syndromeM Mori, A L Rothman, I Kurane, et al.
The New England Journal of Medicine|April 7, 1994
Hantavirus pulmonary syndrome: a clinical description of 17 patients with a newly recognized disease. The Hantavirus Study GroupJ S Duchin, F T Koster, C J Peters, et al.
Human Pathology|January 1, 1995
Hantavirus pulmonary syndrome in the United States: a pathological description of a disease caused by a new agentK B Nolte, R M Feddersen, K Foucar, et al.
The Journal of Infectious Diseases|April 1, 1996
Epidemiologic linkage of rodent and human hantavirus genomic sequences in case investigations of hantavirus pulmonary syndromeB Hjelle, N Tórrez-Martínez, F T Koster, et al.
Antiviral Therapy|March 21, 2000
Intravenous ribavirin for hantavirus pulmonary syndrome: safety and tolerance during 1 year of open-label experience. Ribavirin Study GroupL E Chapman, G J Mertz, C J Peters, et al.
Clinical Infectious Diseases : an Official Publication of the Infectious Diseases Society of America|January 5, 2002
Discriminators between hantavirus-infected and -uninfected persons enrolled in a trial of intravenous ribavirin for presumptive hantavirus pulmonary syndromeL E Chapman, B A Ellis, F T Koster, et al.
Pageof 5

Showing results (41-50 of 49) with videos related to

Sort By:
Pageof 5
You have reached the last page of results.This site can display upto 49 results.
Virology|December 24, 1997
Hantavirus pulmonary syndrome: CD8+ and CD4+ cytotoxic T lymphocytes to epitopes on Sin Nombre virus nucleocapsid protein isolated during acute illnessF A Ennis, J Cruz, C F Spiropoulou, et al.
Clinical Infectious Diseases : an Official Publication of the Infectious Diseases Society of America|December 10, 1999
Hantavirus pulmonary syndrome in pregnancyM J Howard, T J Doyle, F T Koster, et al.
Clinical Infectious Diseases : an Official Publication of the Infectious Diseases Society of America|March 1, 1992
Vasculitic and encephalitic complications associated with Coccidioides immitis infection of the central nervous system in humans: report of 10 cases and reviewP L Williams, R Johnson, D Pappagianis, et al.
The Journal of Infectious Diseases|January 7, 1999
High levels of cytokine-producing cells in the lung tissues of patients with fatal hantavirus pulmonary syndromeM Mori, A L Rothman, I Kurane, et al.
The New England Journal of Medicine|April 7, 1994
Hantavirus pulmonary syndrome: a clinical description of 17 patients with a newly recognized disease. The Hantavirus Study GroupJ S Duchin, F T Koster, C J Peters, et al.
Human Pathology|January 1, 1995
Hantavirus pulmonary syndrome in the United States: a pathological description of a disease caused by a new agentK B Nolte, R M Feddersen, K Foucar, et al.
The Journal of Infectious Diseases|April 1, 1996
Epidemiologic linkage of rodent and human hantavirus genomic sequences in case investigations of hantavirus pulmonary syndromeB Hjelle, N Tórrez-Martínez, F T Koster, et al.
Antiviral Therapy|March 21, 2000
Intravenous ribavirin for hantavirus pulmonary syndrome: safety and tolerance during 1 year of open-label experience. Ribavirin Study GroupL E Chapman, G J Mertz, C J Peters, et al.
Clinical Infectious Diseases : an Official Publication of the Infectious Diseases Society of America|January 5, 2002
Discriminators between hantavirus-infected and -uninfected persons enrolled in a trial of intravenous ribavirin for presumptive hantavirus pulmonary syndromeL E Chapman, B A Ellis, F T Koster, et al.
Pageof 5